MedMira (TSXV:MIR) Other Stockholders Equity : C$-0.00 Mil (As of Jan. 2024)

View and export this data going back to 1999. Start your Free Trial

What is MedMira Other Stockholders Equity?

MedMira's Other Stockholders Equity for the quarter that ended in Jan. 2024 was C$-0.00 Mil.

MedMira's quarterly Other Stockholders Equity increased from Jul. 2023 (C$-0.00 Mil) to Oct. 2023 (C$-0.00 Mil) but then declined from Oct. 2023 (C$-0.00 Mil) to Jan. 2024 (C$-0.00 Mil).

MedMira's annual Other Stockholders Equity declined from Jul. 2021 (C$0.03 Mil) to Jul. 2022 (C$-0.00 Mil) but then increased from Jul. 2022 (C$-0.00 Mil) to Jul. 2023 (C$-0.00 Mil).

MedMira Other Stockholders Equity Historical Data

The historical data trend for MedMira's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMira Other Stockholders Equity Chart

MedMira Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Other Stockholders Equity

Get a 7-Day Free Trial

2.75

0.01

0.03

MedMira Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Other Stockholders Equity	Get a 7-Day Free Trial															-	-	-	-	-

MedMira Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

MedMira Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of MedMira's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMira (TSXV:MIR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (TSXV:MIR) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

MMIRF:USA 47M:Germany

Address

155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3

Website

https://www.medmira.com

MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.